肿瘤治疗目录(抗肿瘤药物目录)
放眼全球,癌症无疑是威胁人类健康的头号公敌!庆幸的是,靶向和免疫治疗使癌症逐步成为临床可控的疾病,相比化疗时代,提升了晚期癌症患者的生存时间。
更重要的是,近两年国内外的新药研发快马加鞭,仅2021年美国FDA和中国NMPA获批上市的抗癌新药多达70余种,众多癌症打破了治疗僵局,迎来了首款靶向药物,又有很多幸运的病友们等来了新的希望和治疗选择。
全球肿瘤医生网医学部每年都会参照美国FDA官网及美国国家癌症研究院的药品获批信息,定期为大家整理更新所有癌症获批的靶向药物,2022年伊始,我们特别奉上增加了近两年备受关注的免疫药物用药信息(PD-1,CAR-T)的药品目录供大家参考,还想了解更多新药信息的病友可直接致电全球肿瘤医生网医学部,希望病友们坚定信心战胜癌症!
美国癌症靶向药物更新汇总!(28类癌症)01
肺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/56942191b8f948909a6f3e39a7365b45~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=3jCeDno3aIAmaGlfLP6Io5WYpaw%3D)
02
小细胞肺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/32e3117738aa40ffb09b5e931fa172fb~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=DC9fkruNQ6iNEhF5r%2BApVdg%2Bm%2Fs%3D)
03
乳腺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/09a76ff2e8624ac8870aa81be88a9eec~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=eUqQ3wkwCZbUoHRnRs%2BGdA1ezjA%3D)
04
结直肠癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/102a315edc524da8b1dd6dc0a3fcd879~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=xNf9rHjmeKHpiJ3wtJCgKAZgYvk%3D)
05
胃癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/e0b9dd1020634ee4b91f6a8e3ed446e3~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=GFjZhNzVkJfQKk0s%2BLWvqiPsjEo%3D)
06
胃肠间质瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/397591f11c0a424caf2e3d8a59e8fca6~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=%2FKNHK3zhiQiSJ8EDhl1qJTihHRc%3D)
07
胆管癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/8411439544cc42cdb84c0c12ba28e27d~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=Qi21%2BjZL4iF8R6DzMdL%2FWniQW%2Bc%3D)
08
食管癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/7e0f98c51b7a47c7a5a34bc70f64423f~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=7rVdSbiB%2FdXcdpAdMODEGTfDwyM%3D)
09
胰腺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/06c133687d5f4be78afddaa5831eaed7~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=Bh681H3ms9sXYWelXuzH3czV%2Bmg%3D)
10
肝癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/1f5335c7c9624098b10a8a294d844d74~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=spdX97IR8K3bxq%2BOSZpRmqWmRFY%3D)
11
原发性腹膜癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/a1e05fc07cee4deb87009c21e898341f~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=UXTcSdnhtgYKv6tjAw%2B3SY7KfsM%3D)
12
神经内分泌癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/ffe0703526d543528619760e181de6d0~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=uXjIKHH3kY2%2BbajvwIMRhMdNMdQ%3D)
13
前列腺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/06329a7addbb45659244e5b6e2cb9399~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=ceW5UrRyAYwtnmBghzJ7r9rkeX4%3D)
14
膀胱癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/78da6d969d734ffdbfdc3993408c3ae9~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=9KMXgv7pQpXm5oP9TAY3OaMXJzQ%3D)
15
肾 癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/e02af9cda2bf40b98408c34fbdddead7~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=j1s1Q3ZPyAMOvmhP2PCtZj2KuoU%3D)
16
宫颈癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/7850acb727f74260af051c7d4be0520c~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=gYkeL3fCMrd2V8BJsTAgWDgkE6U%3D)
17
输卵管癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/5148e78427f745c791fb03e3dc2beef2~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=Ep3LNGayUSwu9OLETFjIXORFoFo%3D)
18
卵巢癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/519fc7e14c534c4ea2e50d93361e199e~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=O2K5LPe3P5m9JQHF4yhwskZGZaU%3D)
19
子宫内膜癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/c00101dc74ec45cab3b7bf133991e937~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=BtlgID4Jp4OixCAleaR81jnmprQ%3D)
20
黑色素瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/b402049ae86a45dc93a87c5423924aa5~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=h0r0%2FexdBeyGYbkd4GVQxpdDHtU%3D)
21
默克尔细胞癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/7cdf9f2366944a308dcd5d8099d041df~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=Sq6Q1eNiL1rxqbT2f8p%2FpB42wXk%3D)
22
基底细胞癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/561f41edc0d9468e81b06f2c183cba3c~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=41EzVjx5AsyN%2FSKaLJ69bFL32t4%3D)
23
甲状腺癌
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/960460c6687a443487f2e0cfafe91883~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=fwS8ZzJUthx0urRZHaKiFOPVMqU%3D)
24
头颈部肿瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/1c0045655c1941a79d4e1d50764a1486~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=vLvEiJIY1Vpy7W8GChWT0kHeY1w%3D)
25
软组织肉瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/d19f1d2420ad4f128e3157d8ada4555d~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=AH8bFxHVFSd%2BHDLgEiM1TkakBCc%3D)
26
白血病
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/7b94a610720c4a2abea4813f64f35cd1~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=DGWKmDArEf%2BCuGemxMXMcLD2TqI%3D)
27
淋巴瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/273495c68c4d4cd8bd0cd9346439a835~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=vuh8Pj8ydbEsjLW4IdRqP%2FDaxb0%3D)
28
多发性骨髓瘤
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/f6416541f7a44826bd37e03c2101cc92~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=geuHQP6BOcrwplcz0iHXtTo7gK8%3D)
29
不限癌种
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/ce1e1fc88c1740cfa870ca502c6127bb~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=Q2Etp9Yw7QJQ112%2F1cLl2COvyd0%3D)
01
CAR-T
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/639e166816b5401ba4d4d9f57dadbfcd~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=xWI%2F9oXY%2BriE2JmvJxV4gU0XNzw%3D)
02
免疫检查点抑制剂
![](https://p3-sign.toutiaoimg.com/tos-cn-i-qvj2lq49k0/4807db62485644fba0805cecac9f2a69~tplv-tt-large.jpeg?x-expires=1969570495&x-signature=TtOSgObsAUdZOu3X4W8sE8NMGNw%3D)
注:
1.2021 年 2 月 22 日,阿斯利康已自愿撤回 FDA 对 PD-L1 抑制剂 durvalumab(Imfinzi)用于先前治疗的局部晚期或转移性膀胱癌患者的适应症。
2.2021 年 1 月 4 日,百时美施贵宝在与 FDA 协商后,撤回了 nivolumab 用于治疗小细胞肺癌患者的适应症
3.2021 年 7 月 27 日,制造商百时美施贵宝 (BMS) 已自愿撤回纳武单抗(Opdivo) 作为先前接受索拉非尼治疗的患者的肝细胞癌(HCC)单一疗法的适应症。
我们处在一个充满奇迹的时代,快速发展的医疗科技给人类带来了新的希望。
曾经,癌症是不治之症。但随着抗癌手段的不断更新,尤其是分子靶向药物等新一代治疗方法的出现,人类全面战胜癌症的那天不再遥不可及,让我们一起见证这一天的来临!